Mezigdomide
Mezigdomide is a cereblon E3 ligase modulator developed by Bristol Myers Squibb to treat multiple myeloma. References

{{reflist Cereblon E3 ligase modulators Butyramides Benzonitriles Fluoroarenes Piperazines Piperidinones Isoindolines ...
[...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]